- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-3-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 9 residues within 4Å:- Chain A: E.181, P.182, V.224, N.232, N.346, C.347, V.414, S.415
- Ligands: NAG.35
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.414
- Hydrogen bonds: A:E.181
NAG-NAG-BMA.18: 2 residues within 4Å:- Chain B: N.118, Y.135
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 10 residues within 4Å:- Chain C: E.181, P.182, L.231, N.232, N.346, C.347, R.412, V.414, S.415
- Ligands: NAG.46
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:V.414
NAG-NAG-BMA.30: 4 residues within 4Å:- Chain C: N.118, K.133, Y.135, D.290
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:Y.135
- Hydrogen bonds: C:K.133
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 19 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.35: 3 residues within 4Å:- Chain A: P.261, N.416
- Ligands: NAG-NAG-BMA.4
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain A: C.101, T.102, N.103, K.117
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain A: E.57, N.58
- Chain F: S.16
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain A: K.304, N.308, W.364
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: P.269, N.271, I.292
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain A: N.204, T.206, S.244
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: N.332, S.333
- Ligands: NAG-NAG.13
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: G.323, N.324
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: N.103, G.114, K.117
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: N.308, S.362, W.364
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain B: N.204, T.206, S.244, E.245
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: N.232, P.261, N.416
- Ligands: NAG-NAG-BMA.27
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain C: E.245, N.246, T.248, N.249
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.324
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain C: N.103, R.140, S.157
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: E.57, N.58
- Chain H: S.16
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: K.304, N.308, W.364
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain G: N.99, S.101
Ligand excluded by PLIPNAG.53: 5 residues within 4Å:- Chain H: N.104, R.105, N.106, S.108, E.109
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roark, R.S. et al., Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J.Exp.Med. (2025)


- Release Date
- 2025-05-07
- Peptides
- Envelope glycoprotein Gp120: ABC
47715-a.01 heavy chain: D
44715-a.01 light chain: E
Envelope glycoprotein Gp41: FGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
LF
XG
YH
Z
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-3-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 19 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roark, R.S. et al., Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J.Exp.Med. (2025)


- Release Date
- 2025-05-07
- Peptides
- Envelope glycoprotein Gp120: ABC
47715-a.01 heavy chain: D
44715-a.01 light chain: E
Envelope glycoprotein Gp41: FGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
LF
XG
YH
Z